quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:02:56·9d
SECFiling
Myriad Genetics Inc. logo

SEC Form DEFA14A filed by Myriad Genetics Inc.

MYGN· Myriad Genetics Inc.
Health Care
Original source

Companies

  • MYGN
    Myriad Genetics Inc.
    Health Care

Recent analyst ratings

  • May 21UpdateScotiabank$6.00
  • May 8UpdateWolfe Research-
  • May 7UpdateWells Fargo$6.00
  • Apr 9UpdateGuggenheim-
  • Mar 12UpdatePiper Sandler$12.50
  • Feb 12UpdateCraig Hallum$29.00

Related

  • PR7d
    Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
  • INSIDER8d
    SEC Form 4 filed by Verratti Mark
  • INSIDER8d
    SEC Form 4 filed by Muzzey Dale
  • SEC9d
    SEC Form DEF 14A filed by Myriad Genetics Inc.
  • PR9d
    Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
  • PR14d
    Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Myriad Genetics Inc.
  • INSIDER31d
    SEC Form 4 filed by Verratti Mark
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022